XKRX039840
Market cap164mUSD
Jan 03, Last price
16,650.00KRW
1D
1.96%
1Q
2.40%
Jan 2017
-57.90%
Name
Dio Corp
Chart & Performance
Profile
DIO Corporation manufactures and sells dental implants in South Korea. It offers implant systems, which include UFII int. submerged and no-submerged systems, FTN external systems, protem mini systems, UV active and activators, and instrument kits. The company also provides dental digital solutions and dental products; and cardiovascular medical devices. In addition, it exports its products to approximately 70 countries. The company was formerly known as DSI Co., Ltd and changed its name to DIO Corporation in August 2008. DIO Corporation was founded in 1988 and is headquartered in Busan, South Korea.
Valuation
Title KRW in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | |
Income | |||||||||
Revenues | 155,817,893 18.67% | 131,306,347 -12.48% | |||||||
Cost of revenue | 67,829,406 | 76,542,933 | |||||||
Unusual Expense (Income) | |||||||||
NOPBT | 87,988,486 | 54,763,414 | |||||||
NOPBT Margin | 56.47% | 41.71% | |||||||
Operating Taxes | 7,786,090 | (968,118) | |||||||
Tax Rate | 8.85% | ||||||||
NOPAT | 80,202,396 | 55,731,532 | |||||||
Net income | 3,311,377 -116.19% | (20,457,625) -172.40% | |||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | (5,153,096) | (3,485,757) | |||||||
BB yield | 1.58% | 1.19% | |||||||
Debt | |||||||||
Debt current | 114,104,288 | 107,377,704 | |||||||
Long-term debt | 7,371,106 | 8,597,283 | |||||||
Deferred revenue | 5 | 1,253,595 | |||||||
Other long-term liabilities | 4,359,589 | 3,727,684 | |||||||
Net debt | 90,923,004 | 75,806,194 | |||||||
Cash flow | |||||||||
Cash from operating activities | 5,439,420 | (1,025,971) | |||||||
CAPEX | (4,224,074) | (12,526,143) | |||||||
Cash from investing activities | (2,866,539) | (16,633,377) | |||||||
Cash from financing activities | (10,327,124) | 5,098,914 | |||||||
FCF | 26,216,276 | 70,883,588 | |||||||
Balance | |||||||||
Cash | 11,665,143 | 22,232,052 | |||||||
Long term investments | 18,887,247 | 17,936,740 | |||||||
Excess cash | 22,761,496 | 33,603,475 | |||||||
Stockholders' equity | 79,357,907 | 98,323,703 | |||||||
Invested Capital | 294,113,206 | 249,323,006 | |||||||
ROIC | 29.52% | 21.78% | |||||||
ROCE | 27.75% | 19.32% | |||||||
EV | |||||||||
Common stock shares outstanding | 14,558 | 14,823 | |||||||
Price | 22,400.00 13.71% | 19,700.00 -47.26% | |||||||
Market cap | 326,095,078 11.67% | 292,020,862 -46.55% | |||||||
EV | 417,018,082 | 369,217,486 | |||||||
EBITDA | 100,297,515 | 67,933,222 | |||||||
EV/EBITDA | 4.16 | 5.44 | |||||||
Interest | 7,723,685 | 4,996,081 | |||||||
Interest/NOPBT | 8.78% | 9.12% |